These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 18760581)

  • 1. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
    Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
    Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and utilization of COPD and asthma among insured adults in the US.
    Blanchette CM; Broder M; Ory C; Chang E; Akazawa M; Dalal AA
    Curr Med Res Opin; 2009 Jun; 25(6):1385-92. PubMed ID: 19419342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
    Lin PJ; Shaya FT; Scharf SM
    Respir Med; 2010 May; 104(5):697-704. PubMed ID: 19954941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M; Biddle AK; Stearns SC
    Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.
    Mannino DM; Homa DM; Akinbami LJ; Ford ES; Redd SC
    Respir Care; 2002 Oct; 47(10):1184-99. PubMed ID: 12354338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease.
    Akazawa M; Hayflinger DC; Stanford RH; Blanchette CM
    Am J Manag Care; 2008 Jul; 14(7):438-48. PubMed ID: 18611095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.
    Bilde L; Rud Svenning A; Dollerup J; Baekke Borgeskov H; Lange P
    Respir Med; 2007 Mar; 101(3):539-46. PubMed ID: 16889949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system.
    Mittmann N; Kuramoto L; Seung SJ; Haddon JM; Bradley-Kennedy C; Fitzgerald JM
    Respir Med; 2008 Mar; 102(3):413-21. PubMed ID: 18086519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
    Insinga RP; Ye X; Singhal PK; Carides GW
    Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden of chronic obstructive pulmonary disease.
    Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
    Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease.
    Dalal AA; Shah M; Lunacsek O; Hanania NA
    Respir Med; 2011 Oct; 105(10):1516-22. PubMed ID: 21684731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The direct medical costs of undiagnosed chronic obstructive pulmonary disease.
    Mapel DW; Robinson SB; Dastani HB; Shah H; Phillips AL; Lydick E
    Value Health; 2008; 11(4):628-36. PubMed ID: 18194402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.